Other Income & Expense
Other Non-Cash Items
Regeneron Pharmaceuticals Other Non-Cash Items increased by 59.4% to -$55.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1637.5%, from -$3.20M to -$55.60M. Over 4 years (FY 2021 to FY 2025), Other Non-Cash Items shows an upward trend with a -30.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryProfitability
SignalLower is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026Apr 29, 2026
How to read this metric
Frequent or large adjustments may indicate volatility in non-operating areas or aggressive accounting estimates.
Detailed definition
Aggregated non-cash items that impact net income but do not involve the movement of cash, such as asset impairments, non...
Peer comparison
Commonly found in the 'Adjustments to reconcile net income' section of the cash flow statement.
Metric ID:
cat_other_noncash_income_expenseHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$163.90M | -$71.80M | -$304.30M | -$84.30M | -$54.00M | -$60.70M | -$169.00M | -$20.60M | -$8.60M | $11.80M | $17.50M | -$100.00K | $3.00M | $29.00M | -$68.00M | -$3.20M | $20.90M | -$16.30M | -$136.90M | -$55.60M |
| QoQ Change | — | +56.2% | -323.8% | +72.3% | +35.9% | -12.4% | -178.4% | +87.8% | +58.3% | +237.2% | +48.3% | -100.6% | >999% | +866.7% | -334.5% | +95.3% | +753.1% | -178.0% | -739.9% | +59.4% |
| YoY Change | — | — | — | — | +67.1% | +15.5% | +44.5% | +75.6% | +84.1% | +119.4% | +110.4% | +99.5% | +134.9% | +145.8% | -488.6% | <-999% | +596.7% | -156.2% | -101.3% | <-999% |
Range-$304.30M – $29.00M
CAGR-20.4%
Avg YoY Growth-249.4%
Median YoY Growth+71.3%
Other Non-Cash Items at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's other non-cash items?
- Regeneron Pharmaceuticals (REGN) reported other non-cash items of -$55.60M in Q1 2026.
- How has Regeneron Pharmaceuticals's other non-cash items changed year-over-year?
- Regeneron Pharmaceuticals's other non-cash items decreased by 1637.5% year-over-year, from -$3.20M to -$55.60M.
- What is the long-term trend for Regeneron Pharmaceuticals's other non-cash items?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's other non-cash items has grown at a -30.1% compound annual growth rate (CAGR), from -$568.70M to -$135.50M.
- What does other non-cash items mean?
- Miscellaneous non-cash gains or losses that affect reported earnings.